Henry Ji - 25 Aug 2022 Form 4 Insider Report for Sorrento Therapeutics, Inc.

Role: President, CEO and Chairman of the Board of Directors, Director
Signature: /s/ Henry Ji, Ph.D.
Issuer symbol: N/A
Transactions as of: 25 Aug 2022
Net transactions value: +$76,428
Form type: 4
Filing time: 25 Aug 2022, 17:18:13 UTC
Previous filing: 14 Jun 2022
Next filing: 26 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRNEQ	Common Stock	Purchase	$45,768	+22,222	+1.1%	$2.06^*	2,088,029	25 Aug 2022	Direct
holding	SRNEQ	Common Stock						2,271,693	25 Aug 2022	See Footnote	F1
holding	SRNEQ	Common Stock						40,000	25 Aug 2022	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRNEQ	Call Option (right to buy)	Purchase	$30,660	+1,000		$30.66^*	1,000	25 Aug 2022	Common Stock	100,000	$15.00	By BioVintage, Inc.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.

Remarks:

President, CEO and Chairman of the Board of Directors